Heitor Tavares Santos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Heitor Tavares Santos has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Alexander Rimar
Division of Geriatrics and Palliative Medicine, Department of Medicine, Lenox Hill Hospital, New York, NY, USA
1 shared publication- Dimitrios Karamanis
Department of Economics, University of Piraeus, 18534 Piraeus, Greece
1 shared publication - Dimitrios Sagris
Department of Internal Medicine, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece
1 shared publication - Dimitrios Varrias
NYC Health + Hospitals, Jacobi Hospital, Albert Einstein College of Medicine, Bronx, NY 10461, USA
1 shared publication Edith Burns
Division of Geriatrics and Palliative Medicine, Department of Medicine, Institute of Health Systems Science, Feinstein Institutes for Medical Research, Manhasset, NY, USA
1 shared publication- Eleni Korompoki
Department of Clinical Therapeutics, National and Kapodistrian University of Athens, Athens, Greece
1 shared publication
Latest Publications
- 3 July 2026
- Published by Elsevier in Journal of the American Medical Directors Association
- Vol. 27 (8) , 106323
The Embedded Model for Bridging Essential Delivery of Care in Assisted Living Facilities—EMBED-ALF
- 3 July 2026
- Published by Elsevier in Journal of the American Medical Directors Association
- Vol. 27 (8) , 106323
The Embedded Model for Bridging Essential Delivery of Care in Assisted Living Facilities—EMBED-ALF
- 1 November 2022
- Published by Wolters Kluwer Health in Stroke
- Vol. 53 (11) , 3410-3418
Incidence of Stroke in Randomized Trials of COVID-19 Therapeutics: A Systematic Review and Meta-Analysis
Background: COVID-19 has been frequently associated with an increased risk of thrombotic complications. There have also been reports of an increased likelihood of stroke, although its true incidence in patients with COVID-19 is currently unknown. Methods: Electronic databases PubMed and Scopus were searched from inception up to July 30, 2021 to identify randomized controlled studies in patients with confirmed COVID-19 undergoing one or more interventions. Studies were screened for eligibility using a predefined inclusion criterion and selected using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. A random-effects model meta-analysis was conducted, and heterogeneity was assessed using I-squared test. Results: Out of 3960 potentially eligible articles, 77 randomized studies (38 732 patients) were included. Mean age of the study population was 55±9.3 years. Females constituted 38% of the study population and mean duration of follow-up after study enrollment was 23±12.9 days. Cumulative incidence of stroke in the overall study population was 0.001 (95% CI, 0.001–0.002) with a total of 65 events in 38 732 patients, corresponding to an absolute incidence of 0.168%. Incidence of stroke in the inpatient population was 0.001 (95% CI, 0.001–0.002; 65 events in 37 069 patients), corresponding to an absolute incidence of 0.175%. No strokes were observed in the outpatient setting. Conclusions: The overall incidence of stroke in patients with COVID-19 appears to be lower than that reported in previous observational reports.
- 1 November 2022
- Published by Wolters Kluwer Health in Stroke
- Vol. 53 (11) , 3410-3418
Incidence of Stroke in Randomized Trials of COVID-19 Therapeutics: A Systematic Review and Meta-Analysis
Background: COVID-19 has been frequently associated with an increased risk of thrombotic complications. There have also been reports of an increased likelihood of stroke, although its true incidence in patients with COVID-19 is currently unknown. Methods: Electronic databases PubMed and Scopus were searched from inception up to July 30, 2021 to identify randomized controlled studies in patients with confirmed COVID-19 undergoing one or more interventions. Studies were screened for eligibility using a predefined inclusion criterion and selected using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. A random-effects model meta-analysis was conducted, and heterogeneity was assessed using I-squared test. Results: Out of 3960 potentially eligible articles, 77 randomized studies (38 732 patients) were included. Mean age of the study population was 55±9.3 years. Females constituted 38% of the study population and mean duration of follow-up after study enrollment was 23±12.9 days. Cumulative incidence of stroke in the overall study population was 0.001 (95% CI, 0.001–0.002) with a total of 65 events in 38 732 patients, corresponding to an absolute incidence of 0.168%. Incidence of stroke in the inpatient population was 0.001 (95% CI, 0.001–0.002; 65 events in 37 069 patients), corresponding to an absolute incidence of 0.175%. No strokes were observed in the outpatient setting. Conclusions: The overall incidence of stroke in patients with COVID-19 appears to be lower than that reported in previous observational reports.